Limitations of the barcelona clinic liver cancer staging system with a focus on transarterial chemoembolization as a key modality for treatment of hepatocellular carcinoma
- PMID: 31041024
- PMCID: PMC6490251
- DOI: 10.1002/cld.530
Limitations of the barcelona clinic liver cancer staging system with a focus on transarterial chemoembolization as a key modality for treatment of hepatocellular carcinoma
Figures
Similar articles
-
The New Updated Barcelona Clinic Liver Cancer Staging System: Roles of Trans-arterial Chemoembolization and Homework to Interventional Radiologists.Interv Radiol (Higashimatsuyama). 2023 Aug 11;10:e20220035. doi: 10.22575/interventionalradiology.2022-0035. eCollection 2025 Mar 28. Interv Radiol (Higashimatsuyama). 2023. PMID: 40384895 Free PMC article. Review.
-
DEB TACE for Intermediate and advanced HCC - Initial Experience in a Brazilian Cancer Center.Cancer Imaging. 2017 Feb 6;17(1):5. doi: 10.1186/s40644-017-0108-6. Cancer Imaging. 2017. PMID: 28166821 Free PMC article.
-
Clinical appraisal of the recently proposed Barcelona Clinic Liver Cancer stage B subclassification by survival analysis.J Gastroenterol Hepatol. 2014 Apr;29(4):787-93. doi: 10.1111/jgh.12452. J Gastroenterol Hepatol. 2014. PMID: 24224567
-
Transarterial chemoembolization in hepatocellular carcinoma treatment: Barcelona clinic liver cancer staging system.World J Gastroenterol. 2015 Sep 28;21(36):10327-35. doi: 10.3748/wjg.v21.i36.10327. World J Gastroenterol. 2015. PMID: 26420959 Free PMC article. Review.
-
Transarterial Chemoembolization versus Radiofrequency Ablation for Recurrent Hepatocellular Carcinoma after Resection within Barcelona Clinic Liver Cancer Stage 0/A: A Retrospective Comparative Study.J Vasc Interv Radiol. 2016 Dec;27(12):1829-1836. doi: 10.1016/j.jvir.2016.06.010. Epub 2016 Aug 21. J Vasc Interv Radiol. 2016. PMID: 27553917
Cited by
-
Validation of a Multiplex Hypermethylation-based Blood Test to Detect Hepatocellular Carcinoma: A Prospective Case-control Study.J Clin Exp Hepatol. 2025 Sep-Oct;15(5):102578. doi: 10.1016/j.jceh.2025.102578. Epub 2025 Apr 12. J Clin Exp Hepatol. 2025. PMID: 40485822
-
Study to evaluate the immunomodulatory effects of radiofrequency ablation compared to surgical resection for liver cancer.J Cancer. 2018 Aug 6;9(17):3187-3195. doi: 10.7150/jca.25084. eCollection 2018. J Cancer. 2018. PMID: 30210642 Free PMC article.
-
Therapy of Intermediate-Stage Hepatocellular Carcinoma: Current Evidence and Clinical Practice.Semin Intervent Radiol. 2020 Dec;37(5):456-465. doi: 10.1055/s-0040-1719186. Epub 2020 Dec 11. Semin Intervent Radiol. 2020. PMID: 33328701 Free PMC article. Review.
-
Body Composition Predicts Survival in Patients with Hepatocellular Carcinoma Treated with Transarterial Chemoembolization.Cancer Res Treat. 2018 Apr;50(2):530-537. doi: 10.4143/crt.2017.156. Epub 2017 Jun 1. Cancer Res Treat. 2018. PMID: 28602057 Free PMC article.
-
Scoring systems for the management of oncological hepato-pancreato-biliary patients.Ann Hepatobiliary Pancreat Surg. 2022 Feb 28;26(1):17-30. doi: 10.14701/ahbps.21-113. Ann Hepatobiliary Pancreat Surg. 2022. PMID: 35220286 Free PMC article. Review.
References
-
- El‐Serag HB. Epidemiology of hepatocellular carcinoma in USA. Hepatol Res 2007;37(suppl 2):S88‐S94. - PubMed
-
- Marrero JA, Fontana RJ, Barrat A, Askari F, Conjeevaram HS, Su GL, et al. Prognosis of hepatocellular carcinoma: comparison of 7 staging systems in an American cohort. Hepatology 2005;41:707‐716. - PubMed
-
- Cillo U, Vitale A, Grigoletto F, Farinati F, Brolese A, Zanus G, et al. Prospective validation of the Barcelona Clinic Liver Cancer staging system. J Hepatol 2006;44:723‐731. - PubMed
Publication types
LinkOut - more resources
Full Text Sources